Pharma Reaserch Prod Co Ltd (214450) — Long-term Investment Intensity

Latest as of December 2019: 14.6%

Pharma Reaserch Prod Co Ltd (214450) has a Long-term Investment Intensity of 14.6% as of December 2019. Long-term investments of ₩39.36 Billion represent 14.6% of total assets of ₩269.93 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Pharma Reaserch Prod Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

14.6%
LT Investments / Total Assets

Long-term Investments

₩39.36 Billion
KRW

Total Assets

₩269.93 Billion
KRW

Country

Korea
KQ

Pharma Reaserch Prod Co Ltd Long-term Investment Intensity (2015–2019)

This chart shows how Pharma Reaserch Prod Co Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 14.6%, reflecting long-term investments of ₩39.36 Billion against total assets of ₩269.93 Billion KRW. Explore how well can Pharma Reaserch Prod Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Pharma Reaserch Prod Co Ltd (2015–2019)

The table below presents the year-by-year Long-term Investment Intensity for Pharma Reaserch Prod Co Ltd from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 214450 market cap.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2019 14.6% ₩39.36 Billion ₩269.93 Billion ▲ +0.9 pp
2018 13.7% ₩35.40 Billion ₩258.19 Billion ▼ -9.2 pp
2017 22.9% ₩43.27 Billion ₩189.03 Billion ▲ +8.0 pp
2016 14.9% ₩26.73 Billion ₩179.33 Billion ▲ +7.8 pp
2015 7.1% ₩11.96 Billion ₩169.31 Billion
pp = percentage points